Michele Robertson

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

Kim Fox, Ian Ford, Philippe Gabríel Steg et al. · The Lancet · 2008 · 782 citations

Heart Rate, Cardiovascular Disease, Health Policy +9

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

Isla S. Mackenzie, Ian Ford, George Nuki et al. · The Lancet · 2020 · 322 citations · Full text

Cardiovascular Disease, Gouty Arthritis, Pharmacotherapy +5

Antiarrhythmic effect of carvedilol after acute myocardial infarction

John J.V. McMurray, Lars Køber, Michele Robertson et al. · Journal of the American College of Cardiology · 2005 · 273 citations

Thrombosis, Cardiovascular Disease, Cardiovascular Pharmacology +5

Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation

Stephen Kaptoge, SRK Seshasai, Liang Sun et al. · The Lancet Diabetes & Endocrinology · 2023 · 188 citations · Full text

Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

Chris J. Packard, Ian Ford, Michele Robertson et al. · Circulation · 2005 · 121 citations